FDA says "no" to CBD: Now what? | Eversheds Sutherland (US) LLP
The FDA’s recent decision not to regulate CBD like a food or dietary supplement leaves a multi-billion-dollar industry in a lurch. What’s next, and what should companies do now?
Source: jdsupra.com